Loading…
Rifampicin ($RIF) Price Prediction 2026–2050
Rank #4549Bullish
$0.0002102
-0.36% (24h)
Rifampicin ($RIF) Forecast Summary
Rifampicin is projected to decline to $0.000156 by 2027, a -26% move from its current price of $0.0002102. $RIF is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy. Market sentiment sits at 28/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Solana EcosystemMemeDecentralized Science (DeSci)Solana MemePump.fun EcosystemPump Science EcosystemBinance Alpha Spotlight
Live market data via CoinGecko & CoinMarketCap · updated 7/1/2026
Market Cap
$210.08K
24h Volume
$12.35K
Circulating Supply
999.66M $RIF
All-Time High
$0.2478
Green Days (30d)
14/30
Volatility (30d)
3.54%
Rifampicin ($RIF) Price Prediction Summary
Crypto Fear & Greed Index
Market sentiment today28Fear
Extreme FearNeutralExtreme Greed
$RIF Short-Term Price Forecast
Next 7 days
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 25 | $0.0002026 | $0.0002097 | $0.0002171 | -0.22% |
| Jul 26 | $0.0001993 | $0.0002092 | $0.0002197 | -0.44% |
| Jul 27 | $0.0001967 | $0.0002088 | $0.0002216 | -0.66% |
| Jul 28 | $0.0001944 | $0.0002083 | $0.0002232 | -0.87% |
| Jul 29 | $0.0001924 | $0.0002079 | $0.0002245 | -1.09% |
| Jul 30 | $0.0001906 | $0.0002074 | $0.0002257 | -1.31% |
| Jul 31 | $0.0001889 | $0.000207 | $0.0002267 | -1.52% |
Next 7 weeks
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.0001889 | $0.000207 | $0.0002267 | -1.52% |
| Week 2 | $0.0001791 | $0.0002038 | $0.0002319 | -3.02% |
| Week 3 | $0.0001713 | $0.0002007 | $0.0002351 | -4.50% |
| Week 4 | $0.0001646 | $0.0001976 | $0.0002372 | -5.95% |
| Week 5 | $0.0001587 | $0.0001946 | $0.0002387 | -7.39% |
| Week 6 | $0.0001532 | $0.0001917 | $0.0002397 | -8.80% |
| Week 7 | $0.0001482 | $0.0001887 | $0.0002403 | -10.18% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
What is Rifampicin ($RIF)?
Rifampicin, issued as the $RIF token, represents longevity experiments performed with the compound Rifampicin. These experiments are live-streamed on Pump Science, a gamified longevity research platform where users can speculate on life-extending compounds, stream live experiment data, and submit your own longevity cocktails for testing on model organisms.
Pump Science sits in the Solana Ecosystem and is described as a DeSci and meme-oriented platform within the Pump.fun ecosystem and related categories. Rifampicin is presented as a topic within this ecosystem, tied to longevity research and cellular health concepts.
Rifampicin is traditionally known as an antibiotic, but it’s been gaining attention for its surprising effects on aging. In tiny organisms like C. elegans (a model organism often used in aging research), Rifampicin has been shown to activate the cell’s natural defense mechanisms against stress and damage.
Imagine it as a sort of "cellular coach," encouraging cells to stay healthy and resilient by protecting against harmful oxidative stress and maintaining the quality of proteins within the cell. These protective effects help the worms live longer and healthier lives. While it’s still early days, and we don’t yet know if Rifampicin can do the same in humans, its ability to promote cellular health makes it an exciting area of research in the quest for anti-aging therapies.
Rifampicin Price Prediction Overview
Rifampicin, traded as $RIF, is currently priced at $0.0002102 and has a market cap of $210.08K, ranking 4549 by market cap.
Its history includes an all-time high of $0.2478 and an all-time low of $0.0001592, signaling wide intraday and longer-term volatility in this niche asset. The outlook presented by the forecast shows a path of varying returns across years, with near-term stability and longer-term upside potential.
In the nearer horizon, the 2026 forecast sits at an average of $0.0002102, with a range from $0.0001642 to $0.0002102 and a neutral sentiment. Beyond, the multi-year view highlights bullish years such as 2028, 2029, 2030, and later years like 2040 and 2050, with improving average prices and positive ROIs, tempered by occasional bearish years. The forecast indicates notable upside in the long run, but also acknowledges volatility and uncertainty.
$RIF Market & Technical Analysis
$RIF Key Price Levels
Strong Support−27.5%
$0.0001525
A major floor 27.5% below — a decisive break under it would weaken the trend.
Current Support−21.9%
$0.0001642
The nearest floor, 21.9% below — buyers have tended to step in here.
Current Resistance+2.0%
$0.0002143
Price is pressing into resistance (2.0% away) — a breakout level to watch.
Strong Resistance+66.2%
$0.0003493
A major ceiling 66.2% above — clearing it would confirm fresh momentum.
Key $RIF support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
$RIF Market Analysis
Trend ConsensusMixed
Bullish share of indicators52%
Timeframe AlignmentSplit
Price above 6/12 moving averages50%
Risk AssessmentModerate
~66% annualised volatility55%
Momentum (RSI)Buyers
RSI 59 — buying vs selling pressure59%
A snapshot of $RIF market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
$RIF Indicator Summary
Buy
Based on 26 indicators
- Buy
- 12
- Neutral
- 3
- Sell
- 11
Bearish52% BullishBullish
Indicators computed on daily closing prices.
Moving Averages
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.000207 | Buy | $0.0002073 | Buy |
| MA 10 | $0.0002009 | Buy | $0.0002026 | Buy |
| MA 20 | $0.0001943 | Buy | $0.0001993 | Buy |
| MA 50 | $0.0002111 | Sell | $0.0002124 | Sell |
| MA 100 | $0.0002398 | Sell | $0.0002491 | Sell |
| MA 200 | $0.0002889 | Sell | $0.0004287 | Sell |
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.88 | Neutral |
| Stoch RSI (14) | 97.87 | Sell |
| CCI (20) | 152.71 | Buy |
| Williams %R (14) | -1.71 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 12.05 | Buy |
| Bollinger %B (20,2) | 0.96 | Neutral |
| Stochastic %K (14) | 98.29 | Sell |
| TRIX (15) | -0.27 | Sell |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 77.52 | Sell |
| Momentum (10) | 0.00 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 0.00 | Sell |
| ADX (14) | 17.68 | Neutral |
| ATR (14) | 0.00 | Info |
Pivot Levels
- S3$0.0001374
- S2$0.0001525
- S1$0.0001821
- Pivot$0.0001972
- R1$0.0002268
- R2$0.0002419
- R3$0.0002715
The 30-day technical picture is neutral overall. RSI14 stands at 60, indicating neither overbought nor oversold conditions. The short-term moving averages place the price around the same vicinity, with SMA50 at $0.0002113 and SMA200 at $0.000289.
Near-term support sits at $0.0001642 while resistance is seen at $0.0002143. The 30-day price range spans from $0.0001739 to $0.0002539, offering a narrow corridor for short-term moves. Annualized volatility is high at 70%, underscoring the likelihood of rapid swings within the month.
Rifampicin ($RIF) Price Prediction 2026–2050
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.0001642 | $0.0002102 | $0.0002102 | 0% | Neutral | |
| $0.0001209 | $0.000156 | $0.0002146 | -26% | Bearish | |
| $0.0002454 | $0.0003281 | $0.0004723 | +56% | Bullish | |
| $0.0002062 | $0.0002841 | $0.0004234 | +35% | Bullish | |
| $0.0001863 | $0.0002639 | $0.0004049 | +26% | Bullish | |
| $0.0001077 | $0.0001564 | $0.0002461 | -26% | Bearish | |
| $0.0002113 | $0.0003139 | $0.0005054 | +49% | Bullish | |
| $0.0002754 | $0.0004182 | $0.0006872 | +99% | Bullish | |
| $0.0001787 | $0.0002771 | $0.0004639 | +32% | Bullish | |
| $0.000113 | $0.0001787 | $0.0003045 | -15% | Neutral | |
| $0.0002473 | $0.0004294 | $0.0007865 | +104% | Bullish | |
| $0.0002903 | $0.0005949 | $0.00121 | +183% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
Rifampicin ($RIF) 2026 Monthly Forecast
Current Price $0.0002102Range $0.0001642 – $0.00021020% ROI
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.0001642 | $0.0002102 | $0.000266 | +0.00% |
| August 2026 | $0.0001588 | $0.0001894 | $0.0002335 | -9.85% |
| September 2026 | $0.000143 | $0.0001721 | $0.0002148 | -9.17% |
| October 2026 | $0.0001625 | $0.0001969 | $0.0002486 | +14.44% |
| November 2026 | $0.0001595 | $0.0001944 | $0.0002477 | -1.26% |
| December 2026 | $0.0001246 | $0.0001529 | $0.0001964 | -21.39% |
Click any year to see its month-by-month $RIF forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Rifampicin ($RIF) Year-by-Year Price Prediction
Rifampicin ($RIF) Price Prediction 2026
Rifampicin's 2026 outlook centres on $0.0002102, within a $0.0001642 to $0.0002102 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
Rifampicin ($RIF) Price Prediction 2027
By 2027, $RIF could reach as high as $0.0002146, with a base case around $0.000156 and support toward $0.0001209 — roughly -26% from $0.0002102. Expect choppier, lower action through this leg of the cycle.
Rifampicin ($RIF) Price Prediction 2028
Expect $RIF to range from $0.0002454 to $0.0004723 through 2028. The $0.0003281 average target implies a +56% move from current prices. That is up +110% on the projected 2027 average. Momentum favours further upside here.
Rifampicin ($RIF) Price Prediction 2029
The $RIF price prediction for 2029 points to an average of $0.0002841 (low $0.0002062, high $0.0004234) — a potential gain of +35% on today's $0.0002102. Buyers look set to stay in control over this stretch.
Rifampicin ($RIF) Price Prediction 2030
In 2030, $RIF is projected to trade between $0.0001863 and $0.0004049, averaging $0.0002639 — a potential gain of +26% from today's $0.0002102. That is -7% versus the projected 2029 average. Momentum favours further upside here.
Rifampicin ($RIF) Price Prediction 2031
Rifampicin's 2031 outlook centres on $0.0001564, within a $0.0001077 to $0.0002461 range. That is -41% versus the projected 2030 average. That marks a -26% change versus current levels. Expect choppier, lower action through this leg of the cycle.
Rifampicin ($RIF) Price Prediction 2032
By 2032, $RIF could reach as high as $0.0005054, with a base case around $0.0003139 and support toward $0.0002113 — roughly +49% from $0.0002102. Momentum favours further upside here.
Rifampicin ($RIF) Price Prediction 2033
Expect $RIF to range from $0.0002754 to $0.0006872 through 2033. The $0.0004182 average target implies a +99% move from current prices. That is up +33% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Rifampicin ($RIF) Price Prediction 2034
The $RIF price prediction for 2034 points to an average of $0.0002771 (low $0.0001787, high $0.0004639) — a potential gain of +32% on today's $0.0002102. Momentum favours further upside here.
Rifampicin ($RIF) Price Prediction 2035
In 2035, $RIF is projected to trade between $0.000113 and $0.0003045, averaging $0.0001787 — a potential decline of -15% from today's $0.0002102. That is -36% versus the projected 2034 average. A consolidation phase looks the most probable path here.
Rifampicin ($RIF) Price Prediction 2040
Rifampicin's 2040 outlook centres on $0.0004294, within a $0.0002473 to $0.0007865 range. That is up +140% on the projected 2035 average. That marks a +104% change versus current levels. Momentum favours further upside here.
Rifampicin ($RIF) Price Prediction 2050
By 2050, $RIF could reach as high as $0.00121, with a base case around $0.0005949 and support toward $0.0002903 — roughly +183% from $0.0002102. Buyers look set to stay in control over this stretch.
Investment Calculator
Scenario
Investing $1,000 in $RIF today (≈ 4,758,505.82917 $RIF) could be worth
$2,830.84
+$1,830.84 (+183%) by 2050 · US Dollar
Based on the average projected $RIF price of $0 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
$RIF tools
If You Had Invested in Rifampicin
See what a past investment in $RIFwould be worth at today's price.
Invested
$1,000 invested in $RIF on Jul 1, 2025 (≈ 434,718.370999 $RIF) would be worth
$91.36
-$908.64 (-90.9%) today · 0.09× · US Dollar
Based on a $RIF entry price of $0.0023 vs. today's $0.00021.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.000188 | $1,118.06 | +11.8% |
| 1 month ago | $0.000216 | $973.31 | -2.7% |
| 3 months ago | $0.000238 | $883.83 | -11.6% |
| 6 months ago | $0.000424 | $495.28 | -50.5% |
| 1 year ago | $0.0023 | $91.36 | -90.9% |
| All time (1.1y) ago | $0.00246 | $85.42 | -91.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Will $RIF reach a target price?
Enter a price to see how it sits against our $RIF forecast.
Likely(2.0× current price)
Our base-case forecast reaches $0.00042 around 2040.
Implied market cap at $0.00042: $419.86K
Rifampicin Long-Term Forecast (2026–2050)
In the multi-year forecast, the 2030 average price is $0.0002639 with a 25.6% ROI and a bullish sentiment. The longer-horizon picture shows continued upside into 2040, with an average of $0.0004294 and a 104.3% ROI, still bullish. By 2050, the average is $0.0005949 with a 183.1% ROI, also bullish.
The forecast also highlights several bear years, including 2027 with a -25.8% ROI and 2031 with -25.6%, as well as a -15% ROI in 2035, reflecting ongoing volatility. These figures illustrate a wide range of possible outcomes and emphasize that these are estimates, not guarantees. Investors should weigh the potential for substantial upside against the risk of drawdowns in intermediate years.
$RIF Frequently Asked Questions
Tap a question to reveal the answer.
What will Rifampicin be worth in 2030?
Forecast for 2030 shows avg $0.0002639 with min $0.0001863 and max $0.0004049, ROI 25.6%, sentiment BULLISH.
Is Rifampicin a good investment?
Forecasts show both bullish years (e.g., 2028 ROI 56.1%, 2033 ROI 99%) and bearish years (e.g., 2027 ROI -25.8%, 2031 ROI -25.6%). These are estimates and not guarantees, and the asset remains highly volatile.
Can Rifampicin reach $0.001?
The forecast max for 2050 is $0.00121, indicating a path to around that level in the long run under certain scenarios.
What is the current price of Rifampicin ($RIF)?
Current price: $0.0002102.
What is the all-time high for Rifampicin?
All-time high: $0.2478.
Rifampicin Community Discussion
0Share your Rifampicin price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.